Custom Packaging
End-to-end branded packaging experience from vials to mailers for patient delight
Service · OtherCompany source
Company profile
About Truepill
FuzeRx, formerly known as Truepill, is a pharmacy technology and services company that empowers healthcare organizations with configurable, end-to-end digital pharmacy solutions. The company serves life sciences companies, payers, healthcare providers, and consumer health brands with a comprehensive platform that integrates dispensing, hub services, API connectivity, and white-label virtual pharmacy capabilities into a single automated solution. FuzeRx operates as an accredited mail service and specialty pharmacy with nationwide licensing across all 50 states, delivering over 25 million prescriptions to more than 6 million patients. The platform supports brand, specialty lite, and specialty medication dispensing with flexible delivery options including same-day courier service. Their technology stack includes pre-built Virtual Pharmacy solutions and developer APIs that enable partners to configure and launch branded pharmacy experiences in weeks. The company demonstrates deep therapeutic expertise across women's health, endocrinology, and immunology, with particular strength in specialty fertility pharmacy and complex device-dependent therapies like insulin pumps and CGM systems. FuzeRx's Access+ hub service accelerates the path from prescription to treatment for high-performance therapies, while their dispensing capabilities feature custom branded packaging options and broad insurance network coverage supporting 90% of commercially insured patients.
Company description Truepill official website
Primary marketPharmacy & Medication Management
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Truepill?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Autoimmune conditions
- Diabetes
- Endocrinology
- Fertility
- Inflammatory conditions
- Menopause
- Postpartum depression
- Women's health
Who it serves
- Consumer Health Brands
- Healthcare Providers
- Hubs
- Life Sciences Companies
- Payers
Deployment & integration
Api Only · Cloud Saas · Hybrid · Other deployment with recorded integration context.
Geographic context
MarketsUnited States (all 50 states)
Company sourceOfficial website
Company milestones
Platform expansion
Successfully launched over 30 programs for pharmacy services and Stars/HEDIS metrics. Company rebranded from Truepill to FuzeRx (now part of Fuze Health).
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
FuzeRx Access+
Connected hub experience designed to accelerate therapy's path from prescription to treatment for high-performance therapies
Platform · HybridCompany source
FuzeRx APIs
API connectivity for creating custom pharmacy applications with configurable platform integration
Api · Api OnlyCompany source
FuzeRx Dispensing
Brand, specialty lite and specialty medication dispensing with faster speed-to-fill and flexible nationwide home delivery
Service · HybridCompany source
FuzeRx Virtual Pharmacy
Seamless, all-in-one platform that unites hub services and dispensing, customizable to your brand's needs and workflows
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
25M+ prescriptions delivered
Total prescription volume
6M+ patients served
Total patient reach
41%+ prescriptions processed within 2 minutes
Processing speed efficiency
81 NPS
Net Promoter Score for patient satisfaction
90% payer coverage
Insurance network breadth
75%+ new prescription conversion rate
NRx conversion success
Aggregate Customer Base
End-to-end pharmacy services across multiple therapeutic areas including women's health, endocrinology, and immunology
25M+ prescriptions delivered, 6M+ patients served, 41%+ prescriptions processed within 2 minutes, 81 NPS score, 90% payer coverage, 75%+ new prescription conversion rate
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Truepill
Recent articles published on Truepill's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Pharmacy & Medication Management
Companies using AI for medication optimization, pharmacy automation, drug pricing and access, medication adherence, polypharmacy management, or pharmacy workflow optimization. Includes platforms that help patients access affordable medications, tools that reduce medication errors, and AI systems that optimize drug regimens for complex patients.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.